As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Proteasome Inhibitors Market: By Product: Velcade, Kyprolis, Ninlaro, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments

Global Proteasome Inhibitors Market Outlook

The global proteasome inhibitors market is expected to grow at a CAGR of 8.4% in the forecast period of 2021-2026 to reach nearly USD 2.3 billion by 2026.

 

Global Proteasome Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry is expanding due to the development in the research sector, providing treatment for multiple myeloma and drugs to treat pancreatic cancer. North America held the largest market share in 2018, however, it is anticipated to witness a slower growth during the forecast period because of the rising number of substitutes approved by the government, especially in the United States.

 

Properties and Applications

Proteasome inhibitors help in the prevention or delay in the degradation of proapoptotic factors. It facilitates the programmed cell death that ultimately cures the disease. The various product types of proteasome inhibitors are:

 

Global Proteasome Inhibitors Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Velcade
  • Kyprolis
  • Ninlaro
  • Others

The EMR report looks into the regional proteasome inhibitors markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Proteasome Inhibitors Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global proteasome inhibitors market is being driven by the enormous unmet demand and expanding applications of proteasome inhibitors in the treatment of blood cancer and primarily myeloma. The industry is further aided by the rising prevalence of cancer, globally, as proteasome has proved to be efficient for treating cancer indications. The ability of the drug is prompting vendors to conduct studies on the therapeutics effects of the product on solid tumours, hence, promoting the growth of the industry. The other factor leading to the growth of the proteasome inhibitors market is the application of proteasome inhibitors in the treatment of various health conditions. North America accounted for the largest industry share in 2018 due to the high incidences of multiple myeloma and non-Hodgkin’s lymphoma in the region. However, Europe and Asia, are expected to witness a significant growth during the forecast period owing to increased incidences of myeloma and rising sales of proteasome inhibitors in the regions.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global proteasome inhibitors market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Allergan Plc (NYSE: AGN)
  • Amgen Inc. (NASDAQ: AMGN)
  • Celgene Corp. (NASDAQ: CELG)
  • Johnson & Johnson Services Inc. (NYSE: JNJ)
  • Takeda Pharmaceutical Co. Ltd. (TYO: 4502)
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region
Breakup by Product Velcade, Kyprolis, Ninlaro, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Allergan Plc (NYSE: AGN), Amgen Inc. (NASDAQ: AMGN), Celgene Corp. (NASDAQ: CELG), Johnson & Johnson Services Inc. (NYSE: JNJ), Takeda Pharmaceutical Co. Ltd. (TYO: 4502), Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

Key Questions Answered in the Report

  • How has the global proteasome inhibitors market performed in the previous years (2016-2020)?
  • What is the forecast assessment of the global proteasome inhibitors market for 2021-2026?
  • What are the major drivers for the historical (2016-2020) & Forecast (2021-2026)?
  • What are the major constraints for the historical (2016-2020) & Forecast (2021-2026) periods?
  • What are the major demand indicators of the global industry?
  • Who are the key manufacturers of velcade, kyprolis, ninlaro, and others in the global industry?
  • What is the degree of competition in the global industry?
  • What are the major events and developments taking place within the industry, globally?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Proteasome Inhibitors Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Proteasome Inhibitors Historical Market (2016-2020) 
    8.3    Global Proteasome Inhibitors Market Forecast (2021-2026)
    8.4    Global Proteasome Inhibitors Market by Product
        8.4.1    Velcade
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)  
        8.4.2    Kyprolis
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Ninlaro
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Others
    8.5    Global Proteasome Inhibitors Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price 
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    AbbVie Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Celgene Corporation
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Johnson & Johnson Services Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    The Takeda Pharmaceutical Company Limited
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Proteasome Inhibitors Market: Key Industry Highlights, 2016 and 2026
2.    Global Proteasome Inhibitors Historical Market: Breakup by Product (USD Million), 2016-2020
3.    Global Proteasome Inhibitors Market Forecast: Breakup by Product (USD Million), 2021-2026
4.    Global Proteasome Inhibitors Historical Market: Breakup by Region (USD Million), 2016-2020
5.    Global Proteasome Inhibitors Market Forecast: Breakup by Region (USD Million), 2021-2026
6.    North America Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2016-2020
7.    North America Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2021-2026
8.    Europe Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2016-2020
9.    Europe Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2021-2026
10.    Asia Pacific Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2016-2020
11.    Asia Pacific Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Latin America Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Latin America Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Middle East and Africa Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Middle East and Africa Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Global Proteasome Inhibitors Market Structure

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER